Woo AY - Search Results

1

Deregulation of RGS2 in cardiovascular diseases.

Tsang S, Woo AY, Zhu W, Xiao RP. Tsang S, et al. Among authors: woo ay. Front Biosci (Schol Ed). 2010 Jan 1;2(2):547-57. doi: 10.2741/s84. Front Biosci (Schol Ed). 2010. PMID: 20036967 Free PMC article. Review.

2

RGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signaling.

Chakir K, Zhu W, Tsang S, Woo AY, Yang D, Wang X, Zeng X, Rhee MH, Mende U, Koitabashi N, Takimoto E, Blumer KJ, Lakatta EG, Kass DA, Xiao RP. Chakir K, et al. Among authors: woo ay. J Mol Cell Cardiol. 2011 Jun;50(6):1000-7. doi: 10.1016/j.yjmcc.2011.01.015. Epub 2011 Feb 1. J Mol Cell Cardiol. 2011. PMID: 21291891 Free PMC article.

3

Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis.

Zhu W, Woo AY, Yang D, Cheng H, Crow MT, Xiao RP. Zhu W, et al. Among authors: woo ay. J Biol Chem. 2007 Apr 6;282(14):10833-9. doi: 10.1074/jbc.M611507200. Epub 2007 Feb 12. J Biol Chem. 2007. PMID: 17296607 Free article.

4

Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes.

Woo AY, Wang TB, Zeng X, Zhu W, Abernethy DR, Wainer IW, Xiao RP. Woo AY, et al. Mol Pharmacol. 2009 Jan;75(1):158-65. doi: 10.1124/mol.108.051078. Epub 2008 Oct 7. Mol Pharmacol. 2009. PMID: 18838481 Free PMC article.

5

Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptor.

Woo AY, Jozwiak K, Toll L, Tanga MJ, Kozocas JA, Jimenez L, Huang Y, Song Y, Plazinska A, Pajak K, Paul RK, Bernier M, Wainer IW, Xiao RP. Woo AY, et al. J Biol Chem. 2014 Jul 11;289(28):19351-63. doi: 10.1074/jbc.M114.558882. Epub 2014 May 15. J Biol Chem. 2014. PMID: 24831005 Free PMC article.

6

β-Adrenergic receptor subtype signaling in heart: from bench to bedside.

Woo AY, Xiao RP. Woo AY, et al. Acta Pharmacol Sin. 2012 Mar;33(3):335-41. doi: 10.1038/aps.2011.201. Epub 2012 Jan 30. Acta Pharmacol Sin. 2012. PMID: 22286918 Free PMC article. Review.

7

Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.

Woo AY, Song Y, Xiao RP, Zhu W. Woo AY, et al. Br J Pharmacol. 2015 Dec;172(23):5444-56. doi: 10.1111/bph.12965. Epub 2014 Dec 17. Br J Pharmacol. 2015. PMID: 25298054 Free PMC article. Review.

8

Discovery of β-arrestin-biased β₂-adrenoceptor agonists from 2-amino-2-phenylethanol derivatives.

Woo AY, Ge XY, Pan L, Xing G, Mo YM, Xing RJ, Li XR, Zhang YY, Wainer IW, Cheng MS, Xiao RP. Woo AY, et al. Acta Pharmacol Sin. 2019 Aug;40(8):1095-1105. doi: 10.1038/s41401-018-0200-x. Epub 2019 Jan 14. Acta Pharmacol Sin. 2019. PMID: 30643208 Free PMC article.

9

Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.

Ahmet I, Krawczyk M, Zhu W, Woo AY, Morrell C, Poosala S, Xiao RP, Lakatta EG, Talan MI. Ahmet I, et al. Among authors: woo ay. J Pharmacol Exp Ther. 2008 May;325(2):491-9. doi: 10.1124/jpet.107.135335. Epub 2008 Feb 20. J Pharmacol Exp Ther. 2008. PMID: 18287209

10

Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor.

Woo AY, Song Y, Zhu W, Xiao RP. Woo AY, et al. Br J Pharmacol. 2015 Dec;172(23):5477-88. doi: 10.1111/bph.13049. Epub 2015 Feb 27. Br J Pharmacol. 2015. PMID: 25537131 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page